Genmab — Juni 2018
-
Vi håber for alle parter at der kommer nogle gode resultater i H2 eller tidligt i 2019

-
-
EMA restricts use of Keytruda and Tecentriq in bladder cancer http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/05/news_detail_002964.jsp&mid=WC0b01ac058004d5c1
-
og hvad har de 2 med Genmab at gøre?
-
"Markedsværdien skal tre- eller firdobles fra hvor vi er lige nu, baseret på vores produkter," siger Jan van de Winkel til Bloomberg. https://medwatch.dk/Medicinal___Biotek/article10652770.ece
-
bb2121 præsentation lige omkring midnat vil være det vigtigste I dag på ASCO, da det jo vedrører en konkurrent til Darzalex
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind